PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Tziortzouda P, Steyaert J, Scheveneels W, Sicart A, Stoklund Dittlau K, Barbosa Correia AM, Burg T, Pal A, Hermann A, Van Damme P, Moens TG, Van Den Bosch L.
Tziortzouda P, et al. Among authors: moens tg.
Acta Neuropathol. 2024 Feb 16;147(1):41. doi: 10.1007/s00401-024-02689-y.
Acta Neuropathol. 2024.
PMID: 38363426
Free PMC article.